Screener
Monopar Therapeutics MNPR Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $366.66M.
The source filing: Monopar Therapeutics’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 2:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-016982
FAQ
- What is Monopar Therapeutics's market capitalization?
- Monopar Therapeutics (MNPR) reported market capitalization of $366.66M in Q1 2026.
- How has Monopar Therapeutics's market capitalization changed year-over-year?
- Monopar Therapeutics's market capitalization increased by 65.0% year-over-year, from $222.19M to $366.66M.
- What is the long-term trend for Monopar Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Monopar Therapeutics's market capitalization has grown at a 2.5% compound annual growth rate (CAGR), from $385.27M to $436.37M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Monopar Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude